EPCAM and cancer: EpCAM is not present in cells of hematopoietic or mesenchymal origin, and is downregulated in CTCs of epithelial origin which have undergone the epithelial-to-mesenchymal transition.21 Therefore, although EpCAM is the extant gold standard, it cannot serve as a pan-cancer screening affinity ligand.